TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i |
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii |
Allergy Therapeutics PLC
|
2 Reason for the notification (please tick the appropriate box or boxes): |
||
An acquisition or disposal of voting rights |
X |
|
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
||
An event changing the breakdown of voting rights |
||
Other (please specify): |
|
|
3. Full name of person(s) subject to the notification obligation: iii |
SOUTHERN FOX INVESTMENTS LTD. |
4. Full name of shareholder(s) (if different from 3.): iv |
CHASE NOMINEES LTD -CMBLJPPB |
5. Date of the transaction and date on which the threshold is crossed or reached: v |
17th November, 2015 |
6. Date on which issuer notified: |
2nd December, 2015 |
7. Threshold(s) that is/are crossed or reached: vi, vii |
Over 21.66% |
8. Notified details: |
||||||||
A: Voting rights attached to shares viii, ix |
||||||||
Class/type of
|
Situation previous |
Resulting situation after the triggering transaction |
||||||
Number |
Number |
Number |
Number of voting |
% of voting rights x |
||||
Direct |
Direct xi |
Indirectxii |
Direct |
Indirect |
||||
Ord GBP 0.01
GB00B02LCQ05 |
125,348,783 |
125,348,783 |
127,133,783 |
127,133,783 |
21.66% |